KEGG: spo:SPCC24B10.16c
SPCC24B10.16c is a protein encoded in the genome of Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. This protein belongs to a family of proteins specific to this model organism, which is widely used in cell cycle and molecular biology research. While the specific function of SPCC24B10.16c has not been fully characterized in the provided search results, it likely plays a role in cellular processes similar to other proteins with the SPCC nomenclature, which often function in nuclear processes, cell division, or metabolic pathways in S. pombe. Understanding this protein's function requires experimental approaches using tools like the SPCC24B10.16c antibody to study its localization, interactions, and expression patterns under various physiological conditions.
The SPCC24B10.16c Antibody (catalog number CSB-PA865261XA01SXV) is primarily designed for immunological detection of its target protein in S. pombe samples . Based on patterns observed with similar antibodies in the search results, the most common validated applications likely include:
Western blotting (immunoblotting)
Immunoprecipitation (IP)
Immunofluorescence microscopy
Chromatin immunoprecipitation (ChIP)
ELISA
When designing experiments, researchers should consider performing validation studies for their specific experimental conditions, as antibody performance can vary between applications and sample preparation methods. Positive controls using known S. pombe extracts expressing the target protein are essential for confirming antibody specificity in each application.
For optimal performance and longevity of SPCC24B10.16c Antibody, follow these evidence-based storage and handling guidelines:
Store the antibody at -20°C in a non-frost-free freezer to prevent freeze-thaw damage.
Prepare small aliquots upon first thawing to minimize repeated freeze-thaw cycles.
For working solutions, store at 4°C for up to one month with appropriate preservatives.
Avoid prolonged exposure to room temperature or direct light.
Use sterile techniques when handling the antibody to prevent contamination.
These recommendations align with standard practices for polyclonal antibodies as seen with similar yeast protein antibodies . The manufacturer may provide specific buffer information, which typically includes PBS with glycerol (approximately 50%) and preservatives like proclin300 to maintain stability .
When designing experiments using SPCC24B10.16c Antibody, include these essential controls:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive Control | Confirms antibody activity | Use wild-type S. pombe extracts expressing SPCC24B10.16c |
| Negative Control | Validates specificity | Use SPCC24B10.16c deletion mutant strains |
| Isotype Control | Controls for non-specific binding | Use matching IgG from the same species at equivalent concentration |
| Secondary Antibody Control | Detects secondary antibody artifacts | Omit primary antibody but include secondary antibody |
| Blocking Peptide Control | Confirms epitope specificity | Pre-incubate antibody with immunizing peptide |
These controls are crucial for distinguishing true signals from artifacts and for troubleshooting experimental issues. For advanced applications, include additional controls such as epitope-tagged versions of SPCC24B10.16c to confirm antibody recognition patterns.
Based on patterns observed with similar antibodies to S. pombe proteins, the recommended dilution ranges for SPCC24B10.16c Antibody typically vary by application:
| Application | Recommended Dilution Range | Optimization Strategy |
|---|---|---|
| Western Blotting | 1:1000 - 1:5000 | Start with 1:2000 and adjust based on signal-to-noise ratio |
| Immunofluorescence | 1:100 - 1:500 | Begin with 1:200 and titrate as needed |
| Immunoprecipitation | 1:50 - 1:200 | Typically 2-5 μg per mg of total protein |
| ELISA | 1:1000 - 1:10000 | Perform antibody titration to determine optimal concentration |
| ChIP | 1:50 - 1:100 | Usually 2-10 μg per assay |
Optimal dilutions should be determined empirically for each experimental setup and sample type. Start with the manufacturer's recommendations if available and adjust based on signal intensity and background levels. When working with new sample preparations or modified protocols, revalidation of antibody dilutions is advisable.
For challenging applications like detecting low-abundance SPCC24B10.16c protein or working with difficult sample types, consider these optimization strategies:
Enhanced extraction protocols: Use specialized lysis buffers containing appropriate detergents (e.g., 0.1-1% NP-40 or Triton X-100) and protease inhibitors optimized for S. pombe cell walls.
Signal amplification methods: Implement tyramide signal amplification (TSA) for immunofluorescence or enhanced chemiluminescence (ECL) substrates for Western blotting to increase detection sensitivity.
Antigen retrieval techniques: For fixed samples, explore heat-mediated or enzymatic antigen retrieval to expose masked epitopes.
Blocking optimization: Test alternative blocking reagents (BSA, normal serum, commercial blockers) to reduce background while preserving specific signal.
Sample enrichment: Consider subcellular fractionation or immunoprecipitation to concentrate the target protein before detection.
These approaches have proven successful for detecting challenging proteins in yeast samples and can be adapted for SPCC24B10.16c research. Document all optimization steps thoroughly to ensure reproducibility across experiments and research groups.
Cross-reactivity assessment is crucial for ensuring experimental validity, especially when studying protein families with structural similarities. To comprehensively evaluate SPCC24B10.16c Antibody cross-reactivity:
Sequence homology analysis: Compare the SPCC24B10.16c sequence with related proteins in S. pombe and other species to identify potential cross-reactive targets based on epitope similarities.
Knockout validation: Test the antibody on samples from SPCC24B10.16c deletion strains to confirm absence of signal.
Heterologous expression systems: Express SPCC24B10.16c and related proteins individually in systems like E. coli or mammalian cells to test antibody specificity.
Peptide competition assays: Perform Western blots or immunostaining with and without pre-incubation with the immunizing peptide to confirm epitope-specific binding.
Mass spectrometry validation: Identify all proteins captured by immunoprecipitation with SPCC24B10.16c Antibody to detect any off-target interactions.
Cross-reactivity studies are especially important when working with conserved protein domains or when extending research to other yeast species or filamentous fungi. Document all observed cross-reactivity patterns to inform experimental design and data interpretation.
For accurate subcellular localization studies of SPCC24B10.16c protein using its specific antibody:
Fixation optimization: Test multiple fixation methods (formaldehyde, methanol, glutaraldehyde) to preserve both antigenicity and cellular architecture.
Permeabilization calibration: Optimize detergent concentration and exposure time to ensure antibody access to intracellular compartments without disrupting structures.
Co-localization markers: Include antibodies against known compartment markers (nuclear, ER, Golgi, mitochondrial, etc.) to precisely define SPCC24B10.16c localization.
Super-resolution microscopy: Consider techniques like STED, STORM, or SIM for detailed localization beyond diffraction-limited microscopy.
Dynamic localization studies: Examine SPCC24B10.16c localization under various physiological conditions and cell cycle stages to identify potential translocation events.
Correlative approaches: Combine immunofluorescence with electron microscopy for ultrastructural localization confirmation.
For validation, compare antibody-based localization with complementary approaches like GFP-tagged SPCC24B10.16c expressed at endogenous levels. This multi-method strategy provides robust evidence for the true subcellular distribution of the target protein.
Epitope masking can occur due to protein-protein interactions, post-translational modifications, or conformational changes in SPCC24B10.16c. To overcome these challenges:
Denaturing conditions: For Western blotting, ensure complete denaturation using appropriate SDS concentrations and heating protocols optimized for yeast samples.
Multiple antibody approach: If available, use antibodies targeting different epitopes of SPCC24B10.16c to provide complementary detection capability.
Post-translational modification consideration: Phosphorylation, ubiquitination, or other modifications may mask epitopes. Consider using phosphatase treatment or other enzymatic approaches to remove modifications when appropriate.
Native vs. denatured detection comparison: Compare results between native conditions (for IP, native PAGE) and denaturing conditions to identify potential masking issues.
Alternative extraction methods: Test different lysis buffers and detergent combinations that may better solubilize protein complexes while preserving antibody recognition.
Understanding the specific epitope recognized by the SPCC24B10.16c Antibody is crucial for interpreting potential masking effects. This information may be available from the manufacturer or can be determined experimentally through epitope mapping techniques.
For holistic characterization of SPCC24B10.16c protein function, integrate antibody-based detection with complementary methodologies:
Proteomics integration: Combine immunoprecipitation using SPCC24B10.16c Antibody with mass spectrometry to identify interaction partners and post-translational modifications.
ChIP-seq applications: If SPCC24B10.16c has DNA-binding capacity, use ChIP-seq to map genome-wide binding sites and correlate with transcriptional effects.
Proximity labeling approaches: Use BioID or APEX2 fusions with SPCC24B10.16c to identify proximal proteins in living cells, complementing traditional co-IP approaches.
Functional correlation: Correlate SPCC24B10.16c protein levels (detected by the antibody) with phenotypic outcomes in various mutant backgrounds or environmental conditions.
Structural biology integration: Use antibody-based purification to obtain SPCC24B10.16c protein for structural studies using X-ray crystallography, cryo-EM, or NMR.
This integrated approach provides multidimensional insights into protein function beyond what any single technique can offer. When designing such comprehensive studies, consider timing of sample collection and processing to ensure compatibility across different methodologies.
Researchers frequently encounter several technical challenges when working with antibodies against S. pombe proteins like SPCC24B10.16c:
High background signal: Address by optimizing blocking conditions (try 5% BSA instead of milk proteins), increasing wash stringency, and titrating antibody concentration.
Weak or absent signal: Improve by adjusting protein extraction methods for better yield, reducing protease activity during sample preparation, and enhancing detection systems.
Non-specific bands: Mitigate by increasing antibody specificity through affinity purification against the immunogen, optimizing washing conditions, and validating with knockout controls.
Batch-to-batch variability: Minimize impact by purchasing larger lots when possible, thoroughly characterizing each new lot, and maintaining reference samples for comparison.
Poor reproducibility: Enhance by standardizing all protocols in detail (including incubation times, temperatures, and buffer compositions) and controlling for variations in sample preparation.
Document all optimization steps meticulously to establish robust protocols that can be consistently applied across experiments and researchers within your laboratory.
When faced with discrepancies between antibody-based detection of SPCC24B10.16c and other methods (e.g., RNA expression, tagged protein detection):
Comprehensive validation: Re-validate antibody specificity using knockout controls and immunoprecipitation followed by mass spectrometry to confirm target identity.
Epitope accessibility assessment: Consider whether protein conformation, interactions, or modifications might affect epitope recognition in different experimental contexts.
Post-transcriptional regulation: Explore whether differences between mRNA and protein levels reflect authentic biological regulation rather than technical artifacts.
Method-specific biases: Evaluate whether each detection method has inherent biases or limitations that could explain discrepancies (e.g., GFP tags affecting protein stability).
Condition-specific effects: Test whether discrepancies are consistent across different growth conditions, cell cycle stages, or genetic backgrounds to identify context-dependent factors.
When reporting such discrepancies in publications, transparently describe all approaches used and consider the biological significance of the differences rather than dismissing them as technical noise.
For successful co-immunoprecipitation (co-IP) studies to identify SPCC24B10.16c interaction partners:
Buffer optimization: Test multiple lysis and binding buffers to identify conditions that preserve biologically relevant interactions while minimizing non-specific binding:
| Buffer Type | Salt Concentration | Detergent | Best For |
|---|---|---|---|
| Stringent | 300-500 mM NaCl | 1% Triton X-100 | Direct interactions |
| Moderate | 150-300 mM NaCl | 0.5% NP-40 | Stable complexes |
| Gentle | 100-150 mM NaCl | 0.1% Digitonin | Weak/transient interactions |
Crosslinking consideration: For transient interactions, evaluate whether chemical crosslinking (e.g., formaldehyde, DSP) before lysis improves complex recovery.
Antibody orientation: Compare direct antibody coupling to beads versus indirect capture with Protein A/G to determine which approach yields better results.
Control selection: Include multiple controls including IgG isotype control, lysate from SPCC24B10.16c deletion strain, and reciprocal IPs when possible.
Elution strategies: Compare different elution methods (peptide competition, pH change, SDS) to optimize recovery while maintaining interacting protein integrity.
Document all optimization steps and standardize final protocols to ensure reproducibility across experiments and researchers.
The SPCC24B10.16c Antibody can be adapted for cutting-edge research applications that extend beyond traditional immunological techniques:
CRISPR-based genomic studies: Use the antibody to validate knockouts or examine the effects of precise genome editing on SPCC24B10.16c expression and function.
Single-cell proteomics: Adapt the antibody for microfluidic-based single-cell Western blotting to examine cell-to-cell variability in SPCC24B10.16c expression.
In situ protein interaction detection: Employ proximity ligation assays (PLA) with SPCC24B10.16c Antibody to visualize and quantify specific protein interactions within intact cells.
Spatial transcriptomics correlation: Combine immunofluorescence using SPCC24B10.16c Antibody with spatial transcriptomics to correlate protein localization with local gene expression patterns.
Antibody-based CRISPR targeting: Use SPCC24B10.16c Antibody conjugated to Cas effectors for targeted epigenetic modifications or visualization of genomic loci if the protein has DNA-binding properties.
These emerging applications represent frontier areas where traditional antibody tools can be adapted for sophisticated interrogation of biological systems with unprecedented resolution and specificity.
For reliable quantification of SPCC24B10.16c protein using antibody-based methods:
Linear detection range determination: Perform serial dilutions of samples to establish the linear range of detection for accurate quantification.
Reference standards: Consider developing purified recombinant SPCC24B10.16c protein standards for absolute quantification.
Normalization strategy: Carefully select loading controls appropriate for your experimental conditions (e.g., total protein stains like Ponceau S often provide better normalization than individual housekeeping proteins).
Technical replication: Include multiple technical replicates to assess method variability and establish confidence intervals for measurements.
Image acquisition parameters: For fluorescence or chemiluminescence detection, ensure image acquisition settings avoid pixel saturation and fall within the linear range of the detector.
Statistical validation: Apply appropriate statistical tests to determine the significance of observed changes in protein levels across experimental conditions.
Quantitative immunoblotting or ELISA approaches require rigorous validation and standardization to yield reliable measurements of protein abundance across different samples or conditions.